ICT BIO 2008 - Combining the Power of ICT with Biomedical Sciences

Major diseases like cancer, neurological and cardiovascular diseases are complex in nature involving environmental, life style, ageing and genetic components. One of the future challenges is to integrate the knowledge of all these different components into robust and fully reliable computer models and "in silico" environments that will help the development and testing of new therapies for better prediction and prevention tools in healthcare.

An integrative research approach is therefore required to better understand the complex mechanisms behind human diseases. In this approach, all processes that occur at multiple levels from molecules to cells, organs and organisms are seen not as separate events but as parts of a multi-scale system which aims at improving the understanding of the human health and diseases.

To face this challenge a new generation of multidisciplinary science fields is emerging at the crossroads of Information Technology, Medicine and Biology that provide "in silico" multi-scale modeling and simulation in medicine and biology. For example, patient-specific computer models of human cells or organs can bring new understanding of disease, support discovery of new drugs or can help visualising the effects of different choices of treatments.

To realise this ambitious vision at the crossroads of Information and Communication Technologies and Biomedical Sciences, researchers from different disciplines must work together on virtually everything that can be observed and measured at multiple biological levels in relation to human physiological diseases. The European Commission is investing in this topic through complementary research programmes in Information and Communication Technologies and Health research.

The Directorate-General Information Society and Media (DG INFSO) supports this integrative research through funding of projects in the area of multi-scale modeling and simulation known as the "Virtual Physiological Human" (VPH) initiative. The Directorate-General Research (DG RTD) supports through funding of projects in the areas of health research and systems biology.

The conference will take place over two days (Oct. 23-24). Each day will start with a plenary session featuring high-level policy speakers including EU Commissioners, Member of Parliaments, prominent scientists and international funding agency representatives from the EU, US and beyond.

In the afternoon, parallel sessions will focus on themes incorporating ICT and life sciences such as multi-scale modeling in cancer research, heart and cardiovascular diseases, muscular-skeleton systems, and ageing. The conference website is updated regularly with the latest information on the sessions and exhibition.

Media events (press-conference, press release, demos to media) will communicate to non-specialists the importance of the synergy between ICT, Biomedical Sciences and Health research and the concrete benefits for all citizens in terms of better healthcare.

During both days an exhibition will be held at the conference venue showcasing amongst others 3D medical imaging and prototypes, interactive audiovisual and technical demonstrations. These demos will be exhibited by on-going research projects showing concrete results in this multidisciplinary research field. The exhibition will be a great opportunity for the public to see the applications of the latest technologies and new tools that will help the development of novel therapies for a more predictive and preventive healthcare.

The Conference is free of charge and online registration is compulsory, entrance will not be permitted without the confirmation letter.

Please note that as the number of seats in the meeting rooms is limited, the Commission reserves the right to confirm, on a free selection basis, only as many registrations as seats available. The confirmation of attendance letter will be sent at the latest on 15th September.

Have Your Say
Logged-in site visitors are able to use the site's 'Comment' function to show their interest in or comment on the event in one of two ways:

  • suggest a contribution - your idea will be forwarded to the session coordinator. If successful, you will be able to develop it further by adding documents;
  • comment on a session - relevant questions and comments will be communicated to the chairman of the session and potentially addressed during the session.

Alongside the conference, the 1st Transatlantic Workshop on Multiscale Cancer Modelling will take place at the same venue.

Computational and mathematical cancer modelling is already a driving force behind interdisciplinary cancer systems biology. Understanding cancer as a complex dynamic bio system requires finding ways to investigate and ultimately target its many constituents and their dynamic relationships across multiple scales in space and time - i.e., multi-scale modelling and simulation. Geared towards translation into clinical practice, long term goals of these modelling approaches include supporting patient specific treatment optimization.

In recognizing the significant contribution of teams on both sides of the Atlantic to this emergent field of in silico oncology, the US National Cancer Institute and the European Commission jointly support a workshop that is being co-organized by NCI’s Center for the Development of a Virtual Tumor, CViT, and EC's Advancing Clinico Genomics Trials Program, ACGT.

This workshop aims to present cutting edge approaches, to demonstrate the field's potential and to discuss common challenges it faces in moving forward. The ideal outcome is facilitated interaction between the teams, increased visibility of the achievements beyond the nascent community and formulation of a shared vision that can be advanced into joint funding programs.

The following modelling and simulation topics will be addressed: carcinogenesis, prevascular and vascular progression, invasion and metastasis, tumour growth across spatiotemporal scales and clinically oriented tumour modelling. All major multilevel approaches i.e. bottom-up, top-down and middle-out will be delineated through carefully selected paradigms. Initiatives regarding translation of multiscale cancer models into the arena of clinical trials will be outlined and their potential will be discussed.

Programme is available at the ICT BIO conference website under the Transatlantic Workshop button.

For further information and registration, please visit:
http://ec.europa.eu/information_society/
events/ict_bio/2008/index_en.htm

Related news articles:

Most Popular Now

Is Your Marketing Effective for an NHS C…

How can you make sure you get the right message across to an NHS chief information officer, or chief nursing information officer? Replay this webinar with Professor Natasha Phillips, former...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

AI can Predict Study Results Better than…

Large language models, a type of AI that analyses text, can predict the results of proposed neuroscience studies more accurately than human experts, finds a new study led by UCL...

Using AI to Treat Infections more Accura…

New research from the Centres for Antimicrobial Optimisation Network (CAMO-Net) at the University of Liverpool has shown that using artificial intelligence (AI) can improve how we treat urinary tract infections...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...